...
首页> 外文期刊>The Biochemical Journal >Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions
【24h】

Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions

机译:人脂肪条纹,中间病变和晚期动脉粥样硬化病变中存在蛋白质结合的对羟基苯乙醛(由髓过氧化物酶产生的氨基酸衍生的醛)水平升高

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Reactive aldehydes might have a pivotal role in the pathogenesis of atherosclerosis by covalently modifying low-density lipoprotein (LDL). However, the identities of the aldehyde adducts that form on LDL in vivo are not yet clearly established. We previously demonstrated that the haem protein myeloperoxidase oxidizes proteins in the human artery wall, We also have shown that p-hydroxyphenylacetaldehyde (pHA), the aldehyde that forms when myeloperoxidase oxidizes L-tyrosine, covalently modifies the N-epsilon-lysine residues of proteins. The resulting Schiff base can be quantified as N-epsilon-[2-(p-hydroxyphenyl)ethyl]lysine (pHA-lysine) after reduction with NaCNBH3. Here we demonstrate that pHA-lysine is a marker for LDL that has been modified by myeloperoxidase, and that water-soluble, but not lipid-soluble, antioxidants inhibit the modification of LDL protein. To determine whether myeloperoxidase-generated aldehydes might modify LDL in vivo, we used a combination of isotope-dilution GC-MS to quantify pHA-lysine in aortic tissues at various stages of lesion evolution, We also analysed LDL isolated from atherosclerotic aortic tissue, Comparison of normal and atherosclerotic aortic tissue demonstrated a significant elevation (more than 10-fold) of the reduced Schiff base adduct in fatty streaks, intermediate lesions and advanced lesions compared with normal aortic tissue. Moreover, the level of pHA-lysine in LDL recovered from atherosclerotic aortic intima was 200-fold that in plasma LDL of healthy donors. These results indicate that pHA-lysine, a specific covalent modification of LDL, is generated in human atherosclerotic vascular tissue. They also raise the possibility that reactive aldehydes generated by myeloperoxidase have a role in converting LDL into an atherogenic lipoprotein. [References: 50]
机译:反应性醛可能通过共价修饰低密度脂蛋白(LDL)在动脉粥样硬化的发病机理中起关键作用。然而,尚不清楚在体内在LDL上形成的醛加合物的身份。先前我们证明了血红素蛋白髓过氧化物酶会氧化人动脉壁上的蛋白质。我们还显示,对羟基苯乙醛(pHA)(当髓过氧化物酶氧化L-酪氨酸时形成的醛)会共价修饰蛋白的N-ε-赖氨酸残基。 。用NaCNBH3还原后,所得的席夫碱可以定量为N-ε-[2-(对羟基苯基)乙基]赖氨酸(pHA-赖氨酸)。在这里,我们证明pHA赖氨酸是髓过氧化物酶修饰的LDL的标志物,水溶性但非脂溶性的抗氧化剂抑制LDL蛋白的修饰。为了确定髓过氧化物酶生成的醛是否可能在体内修饰LDL,我们使用了同位素稀释GC-MS的组合来量化病变发展各个阶段的主动脉组织中的pHA-赖氨酸。我们还分析了从动脉粥样硬化主动脉组织中分离的LDL,比较与正常主动脉组织相比,在正常和动脉粥样硬化的主动脉组织中,脂肪条纹,中度病变和晚期病变中的席夫碱加成物降低的席夫碱加合物的降低幅度显着提高(超过10倍)。此外,从动脉粥样硬化主动脉内膜中恢复的LDL中的pHA-赖氨酸水平是健康供体血浆LDL中的200倍。这些结果表明,在人的动脉粥样硬化的血管组织中产生了LDL的特定共价修饰物pHA-赖氨酸。它们还增加了由髓过氧化物酶产生的反应性醛具有将LDL转化为致动脉粥样硬化脂蛋白的作用的可能性。 [参考:50]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号